Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zhen-Yu Tong

Thoracic Surgery (Cardiothoracic Vascular Surgery) Cleveland, OH Medical Doctor

NPI 1265787394 CMS profile 684068

9500 Euclid Ave # J4-133, Apt/Suite, Cleveland, OH 44195

Open in the dashboard

General payments

$221,847

336 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$47,343 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Zhen-Yu Tong of Cleveland, OH is reported in the CMS Open Payments database as having received $221,847 across 336 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $47,343 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $71,587 44
2024 General $48,621 53
2023 General $42,568 77
2022 General $11,748 45
2021 General $7,059 16
2020 General $19,103 33
2019 General $21,161 68

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zhen-Yu Tong
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Zhen-Yu Tong were reported at $71,587. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Zhen-Yu Tong Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $21,161 $886 $178–$3,167 $163
2020 $19,103 $341 $108–$1,605 $114
2021 $7,059 $453 $125–$1,886 $132
2022 $11,748 $695 $180–$2,566 $149
2023 $42,568 $745 $205–$2,662 $160
2024 $48,621 $799 $214–$2,967 $164
2025 $71,587 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $120,007 215 payments
  2. Abiomed $66,879 46 payments
  3. BrioHealth Solutions, Inc. $12,000 1 payment
  4. Arthrex, Inc. $10,757 4 payments
  5. CVRx, Inc. $4,158 21 payments
  6. Medtronic Vascular, Inc. $3,195 22 payments
  7. Edwards Lifesciences Corporation $2,922 13 payments
  8. Nexus Medical Technologies LLC $594 1 payment
  9. Medistim USA, Inc. $412 2 payments
  10. TransMedics, Inc. $342 1 payment
  11. Other $581 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $112,288 38 payments
  2. Travel and Lodging $47,827 97 payments
  3. Honoraria $26,875 8 payments
  4. Food and Beverage $14,271 181 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,000 6 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $9,588 6 payments
Products named General payments · program years 2019–2025
  1. Impella $47,375 43 payments
  2. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $41,614 111 payments
  3. EPIC $33,490 27 payments
  4. MITRACLIP $22,048 11 payments
  5. HeartMate 3 Left Ventricular Dev $14,906 39 payments
  6. BRIOVAD $12,000 1 payment
  7. HeartMate 3 Left Ventricular Assist Device $6,606 13 payments
  8. Barostim Neo System $4,158 21 payments
  9. HeartWare HVAD $730 11 payments
  10. Trifecta GT Tissue Heart Valve $443 3 payments
  11. Other $2,248 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 80 billing codes

Paid by Medicare

$211,062

Medicare's payments for the services billed

Medicare patients

129

Average age 72

Services billed

372

35 women, 94 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 60%
Heart failure 57%
Arthritis 47%
Diabetes 42%
Chronic kidney disease 37%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

336 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record